Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
2.
Surg Endosc ; 38(3): 1576-1582, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38182799

ABSTRACT

BACKGROUND: Perforated peptic ulcer disease (PPUD) has a prevalence of 0.004-0.014% with mortality of 23.5% (Tarasconi et al. in World J Emerg Surg 15(PG-3):3, 2020). In this single center study, we examined the impact associated with patient transfer from outside facilities to our center for definitive surgical intervention (exploratory laparotomy). METHODS: Using EPIC report workbench, we identified 27 patients between 2018 and 2021 undergoing exploratory laparotomy with a concurrent diagnosis of peptic ulcer disease, nine of which were transferred to our institution for care. We queried this population for markers of disease severity including mortality, length of stay, intensive care unit (ICU) length of stay, and readmission rates. Manual chart reviews were performed to examine these outcomes in more detail and identify patients who had been transferred to our facility for surgery from an outside hospital. RESULTS: A total of 27 patients were identified undergoing exploratory laparotomy for definitive treatment of PPUD. The majority of patients queried underwent level A operations, the most urgent level of activation. In our institution, a Level A operation needs to go to the operating room within one hour of arrival to the hospital. Average mortality for this patient population was 14.8%. The readmission rate was 40.1%, and average length of ICU stay post-operatively was 16 days, with 83% of non-transfer patients requiring ICU admission and 100% of transfer patients requiring ICU admission, although this was not found to be statistically significant. Average length of hospital stay was 27 days overall. For non-transfer patients and transfer patients, LOS was 20 days and 41 days, respectively, which was statistically significant by one-sided t-test (p = 0.05). CONCLUSION: Patients transferred for definitive care of PPUD in a population otherwise notable for high mortality and high readmission rates: their average length of stay compared to non-transfer patients was over twice the length, which was statistically significant. Transferred patients also had higher rates of ICU care requirement although this was not statistically significant. Further inquiry to identify modifiable variables to facilitate the care of transferred patients is warranted, especially in the context of improving quality metrics known to enhance patient outcomes, satisfaction, and value.


Subject(s)
Peptic Ulcer Perforation , Peptic Ulcer , Humans , Length of Stay , Peptic Ulcer Perforation/surgery , Peptic Ulcer/surgery , Intensive Care Units , Laparotomy , Retrospective Studies
3.
Surg Endosc ; 37(9): 7247-7253, 2023 09.
Article in English | MEDLINE | ID: mdl-37407712

ABSTRACT

PURPOSE: Vertical sleeve gastrectomy (VSG) evolved in the early 2000s into the standalone weight loss procedure we see today. While numerous studies highlight VSG's durability for weight loss, and improvements co-morbidities such as type 2 diabetes mellitus and cardiovascular disease, patients with gastroesophageal reflux disease (GERD) have been counseled against VSG due to the concern for worsening reflux symptoms. When considering anti-reflux procedures, VSG patients are unable to undergo traditional fundoplication due to lack of gastric cardia redundancy. Magnetic sphincter augmentation lacks long-term safety data and endoscopic approaches have undetermined longitudinal benefits. Until recently, the only option for patients with a history of VSG with medically refractory GERD has been conversion to roux en Y gastric bypass (RNYGB), however, this poses other risks including marginal ulcers, internal hernias, hypoglycemia, dumping syndrome, and nutritional deficiencies. Given the risks associated with conversion to RNYGB, we have adopted the ligamentum teres cardiopexy as an option for patients with intractable GERD following VSG. METHODS: A retrospective chart review was conducted of patients who had prior laparoscopic or robotic VSG and subsequently GERD symptoms refectory to pharmacological management who underwent ligamentum teres cardiopexy between 2017 and 2022. Pre-operative GERD disease burden, intraoperative cardiopexy characteristics, post-operative GERD symptomatology and changes in H2 blocker or PPI requirements were reviewed. RESULTS: Of the study's 60 patients the median age was 50 years old, and 86% were female. All patients had a diagnosis of GERD through pre-operative assessments and were taking antisecretory medication. Of the 36 patients who have completed their one year follow up, 81% of patients had either a decrease in dosage or cessation of the antisecretory medication at one year following ligamentum teres cardiopexy. CONCLUSION: Ligamentum teres cardiopexy is a viable alternative to RNYGB in patients with a prior vertical sleeve gastrectomy with medical refractory GERD.


Subject(s)
Diabetes Mellitus, Type 2 , Gastric Bypass , Gastroesophageal Reflux , Laparoscopy , Obesity, Morbid , Round Ligaments , Humans , Female , Middle Aged , Male , Obesity, Morbid/surgery , Obesity, Morbid/complications , Retrospective Studies , Diabetes Mellitus, Type 2/complications , Gastroesophageal Reflux/surgery , Gastroesophageal Reflux/complications , Gastric Bypass/methods , Gastrectomy/adverse effects , Gastrectomy/methods , Round Ligaments/surgery , Weight Loss
4.
J Surg Res ; 268: 276-283, 2021 12.
Article in English | MEDLINE | ID: mdl-34392181

ABSTRACT

BACKGROUND: Paraconduit hiatal hernia (PCHH) is a known complication of esophagectomy with significant morbidity. PCHH may be more common with the transition to a minimally invasive approach and improved survival. We studied the PCHH occurrence following minimally invasive esophagectomy to determine the incidence, treatment, and associated risk factors. METHODS: We retrospectively reviewed records of patients who underwent esophagectomy at an academic tertiary care center between 2013-2020. We divided the cohort into those who did and did not develop PCHH, identifying differences in demographics, perioperative characteristics and outcomes. We present video of our laparoscopic repair with mesh. RESULTS: Of 49 patients who underwent esophagectomy, seven (14%) developed PCHH at a median of 186 d (60-350 d) postoperatively. They were younger (57 versus 64 y, P< 0.01), and in cases of resection for cancer, more likely to develop tumor recurrence (71% versus 23%, P= 0.02). There was a significant difference in 2-y cancer free survival of patients with a PCHH (PCHH 19% versus no hernia 73%, P< 0.01), but no significant difference in 5-y overall survival (PCHH 36% versus no hernia 68%, P= 0.18). Five of seven PCHH were symptomatic and addressed surgically. Four PCHH repairs recurred at a median of 409 d. CONCLUSIONS: PCHH is associated with younger age and tumor recurrence, but not mortality. Safe repair of PCHH can be performed laparoscopically with or without mesh. Further studies, including systematic video review, are needed to address modifiable risk factors and identify optimal techniques for durable repair of post-esophagectomy PCHH.


Subject(s)
Hernia, Hiatal , Laparoscopy , Esophagectomy/adverse effects , Esophagectomy/methods , Hernia, Hiatal/epidemiology , Hernia, Hiatal/etiology , Hernia, Hiatal/surgery , Herniorrhaphy/methods , Humans , Incidence , Laparoscopy/adverse effects , Recurrence , Retrospective Studies , Risk Factors , Surgical Mesh/adverse effects
5.
FASEB J ; 29(7): 2959-69, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25805830

ABSTRACT

Obesity promotes insulin resistance associated with liver inflammation, elevated glucose production, and type 2 diabetes. Although insulin resistance is attenuated in genetic mouse models that suppress systemic inflammation, it is not clear whether local resident macrophages in liver, denoted Kupffer cells (KCs), directly contribute to this syndrome. We addressed this question by selectively silencing the expression of the master regulator of inflammation, NF-κB, in KCs in obese mice. We used glucan-encapsulated small interfering RNA particles (GeRPs) that selectively silence gene expression in macrophages in vivo. Following intravenous injections, GeRPs containing siRNA against p65 of the NF-κB complex caused loss of NF-κB p65 expression in KCs without disrupting NF-κB in hepatocytes or macrophages in other tissues. Silencing of NF-κB expression in KCs in obese mice decreased cytokine secretion and improved insulin sensitivity and glucose tolerance without affecting hepatic lipid accumulation. Importantly, GeRPs had no detectable toxic effect. Thus, KCs are key contributors to hepatic insulin resistance in obesity and a potential therapeutic target for metabolic disease.


Subject(s)
Insulin Resistance/physiology , Kupffer Cells/metabolism , Obesity/metabolism , Transcription Factor RelA/antagonists & inhibitors , Animals , Cytokines/metabolism , Drug Delivery Systems , Fatty Liver/genetics , Fatty Liver/metabolism , Fatty Liver/pathology , Gene Silencing , Glucose Tolerance Test , Humans , In Vitro Techniques , Injections, Intravenous , Kupffer Cells/pathology , Lipid Metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Obese , Obesity/genetics , Obesity/pathology , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/genetics , Transcription Factor RelA/genetics
6.
Surg Endosc ; 29(10): 2885-90, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25552229

ABSTRACT

BACKGROUND: Eradication of Helicobacter pylori prior to Roux-en-Y gastric bypass (RYGB) has been advocated as a measure to reduce the complications of anastomotic ulceration. However, evidence to support a causal relationship between preoperative H. pylori status and postoperative anastomotic ulceration is weak. METHODS: Intraoperative gastric biopsies were obtained on consecutive patients who underwent laparoscopic RYGB at our institution from December 2007 to June 2010. These samples were analyzed by Warthin-Starry stain for H. Pylori organisms. Retrospective chart review was conducted to determine the preoperative presence of acid dyspepsia and acid suppression therapy and to determine postoperative ulcer symptoms, smoking, NSAID or steroid use, and compliance with ulcer prophylaxis. The incidence of ulcer visualization, perforation, and stricture were obtained from a prospectively collected database. Fisher's exact test was used for analyzing associations between discrete groups. Multiple logistic regression was used to assess associations between anastomotic ulcer complications and potential predictors. RESULTS: Histologic evaluation for H. pylori was available in 708 of the 728 patients who underwent RYGB. Fourteen patients were lost to follow up leaving 694 patients available for review. H. pylori was positive in 66 (9.5 %) patients who did not go on to receive definitive treatment for eradication. Marginal ulcers or related late complications were seen in a total of 113 (16.3 %) patients. In the H. pylori positive group, five patients (7.6 %) developed ulcer complications compared to 108 (17.1 %) in the H. pylori negative group (p = 0.05). Groups were not different in terms of preoperative demographics, postoperative ulcer prophylaxis compliance, steroid, NSAIDs, and cigarette use. CONCLUSION: The presence of H. pylori infection at the time of RYGB was found to be associated with a significantly lower incidence of anastomotic ulcer complications postoperatively. This study brings into question efforts and expense allocated to identify and eradicate H. pylori prior to RYGB.


Subject(s)
Anastomosis, Surgical , Gastric Bypass , Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Biopsy , Female , Humans , Intraoperative Care , Laparoscopy , Male , Middle Aged , Peptic Ulcer/epidemiology , Postoperative Complications , Stomach/microbiology
7.
Obes Surg ; 25(1): 1-6, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25052254

ABSTRACT

BACKGROUND: The purpose of the study is to investigate the association of preoperative glucose optimization prior to a Roux-en-Y gastric bypass (RYGB) and diabetes remission. METHODS: The study is a retrospective review of 245 patients with a history of diabetes type II and a RYGB from 2008 to 2012 at UMass Memorial Hospital. RESULTS: Patients that benefited from glucose optimization prior to RYGB were more likely to achieve diabetes remission 1 year after surgery. The preoperative glucose optimization intervention demonstrated that when patients decreased their HbA1c prior to surgery by 1 %, these individuals were 68 % more likely to remit (p = 0.015). Duration of diabetes (p = 0.005) and insulin use (p < 0.001) were also significant predictors of remission, whereas age, race, and gender were not. CONCLUSIONS: Our study results indicate that a greater degree of glycemic improvement in response to presurgical medical intervention is associated with higher rates of diabetes remission post-operatively among obese adults with diabetes type II. Conversely, the lack of favorable glycemic response to intensification of medical management predicts a poor glycemic response to bariatric surgery. Further research is needed to determine if this difference is due to physiological factors or is simply an indicator of patient behavior.


Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/surgery , Gastric Bypass , Obesity, Morbid/surgery , Preoperative Care/methods , Adult , Bariatric Surgery/methods , Blood Glucose/drug effects , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Female , Follow-Up Studies , Gastric Bypass/methods , Humans , Male , Middle Aged , Obesity, Morbid/blood , Obesity, Morbid/complications , Obesity, Morbid/diagnosis , Prognosis , Remission Induction , Retrospective Studies , Weight Loss/physiology
9.
Curr Opin Endocrinol Diabetes Obes ; 18(2): 119-28, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21522001

ABSTRACT

PURPOSE OF REVIEW: Roux-en-Y gastric bypass (RYGB) leads to remission of type 2 diabetes mellitus (T2DM) in a majority of patients. This is prompting investigation of RYGB, and other bariatric operations as interventional therapies for T2DM. RECENT FINDINGS: The impact of RYGB is due to an increase in the release of gastrointestinal hormones in response to a meal [glucagon-like peptide, peptide YY, oxyntomodulin]. This effect involves the parasympathetic nervous system. These same hormones are responsible for an early increase in ß-cell secretion of insulin, leading to early remission of T2DM following RYGB. Progressive weight loss leads to a later improvement in peripheral insulin sensitivity, which is required for later remissions, and is responsible for re-emergence of T2DM in individuals who regain weight in long-term follow-up. As the success of bariatric surgery has prompted the emergence of the concept that T2DM is reversible, we offer a theory to predict reversibility of diabetes after bariatric surgery that is based on baseline beta cell function. SUMMARY: This review will improve the understanding of the physiology of bariatric surgery and its impact on T2DM, stimulate investigations into new avenues to treat T2DM, and allow better selection of nonobese individuals for interventional therapy of T2DM.


Subject(s)
Diabetes Mellitus/etiology , Gastric Bypass , Obesity/surgery , Diabetes Mellitus/physiopathology , Diabetes Mellitus/surgery , Humans , Insulin/metabolism , Insulin Resistance , Insulin Secretion , Insulin-Secreting Cells/metabolism , Obesity/complications , Obesity/physiopathology , Treatment Outcome , Weight Loss
10.
Circulation ; 123(2): 186-94, 2011 Jan 18.
Article in English | MEDLINE | ID: mdl-21200001

ABSTRACT

BACKGROUND: Adipose tissue expands in response to excess caloric intake, but individuals prone to deposit visceral instead of subcutaneous adipose tissue have higher risk of metabolic disease. The role of angiogenesis in the expandability of human adipose tissue depots is unknown. The objective of this study was to measure angiogenesis in visceral and subcutaneous adipose tissue and to establish whether there is a relationship between obesity, metabolic status, and the angiogenic properties of these depots. METHODS AND RESULTS: Angiogenic capacity was determined by quantifying capillary branch formation from human adipose tissue explants embedded in Matrigel, and capillary density was assessed by immunohistochemistry. Subcutaneous adipose tissue had a greater angiogenic capacity than visceral tissue, even after normalization to its higher initial capillary density. Gene array analyses revealed significant differences in expression of angiogenic genes between depots, including an increased subcutaneous expression of angiopoietin-like protein 4, which is proangiogenic in an adipose tissue context. Subcutaneous capillary density and angiogenic capacity decreased with morbid obesity, and subcutaneous, but not visceral, adipose tissue angiogenic capacity correlated negatively with insulin sensitivity. CONCLUSIONS: These data imply that subcutaneous adipose tissue has a higher capacity to expand its capillary network than visceral tissue, but this capacity decreases with morbid obesity. The decrease correlates with insulin resistance, suggesting that impairment of subcutaneous adipose tissue angiogenesis may contribute to metabolic disease pathogenesis.


Subject(s)
Intra-Abdominal Fat/blood supply , Neovascularization, Pathologic/physiopathology , Neovascularization, Physiologic/physiology , Obesity/physiopathology , Subcutaneous Fat/blood supply , Adult , Angiopoietin-Like Protein 4 , Angiopoietins/metabolism , Body Mass Index , Gastric Bypass , Humans , Insulin Resistance/physiology , Intra-Abdominal Fat/metabolism , Intra-Abdominal Fat/physiopathology , Middle Aged , Obesity/metabolism , Obesity/surgery , Subcutaneous Fat/metabolism , Subcutaneous Fat/physiopathology
11.
Surg Obes Relat Dis ; 7(1): 60-7, 2011.
Article in English | MEDLINE | ID: mdl-20678967

ABSTRACT

BACKGROUND: Obesity is a strong risk factor for resistance to insulin-mediated glucose disposal, a precursor of type 2 diabetes and other disorders. However, not all obese individuals are insulin resistant. We sought to identify the molecular pathways that might cause obesity-associated insulin resistance in humans by studying the morbidly obese who were insulin sensitive versus insulin resistant, thereby eliminating obesity as a variable. METHODS: Combining gene expression profiling with computational approaches, we determined the global gene expression signatures of omental and subcutaneous adipose tissue samples obtained from similarly obese patients undergoing gastric bypass surgery. RESULTS: Gene sets related to chemokine activity and chemokine receptor binding were identified as most highly expressed in the omental tissue from insulin-resistant compared with insulin-sensitive subjects, independent of the body mass index. These upregulated genes included chemokines (C-C motif) ligand 2, 3, 4, and 18 and interleukin-8/(CC-X motif) ligand 8 and were not differentially expressed in the subcutaneous adipose tissues between the 2 groups of subjects. Insulin resistance, but not the body mass index, was associated with increased macrophage infiltration in the omental adipose tissue, as was adipocyte size, in these morbidly obese subjects. CONCLUSION: Our findings have demonstrated that inflammation of the omental adipose tissue is strongly associated with insulin resistance in human obesity even in subjects with similar body mass index values.


Subject(s)
Adipose Tissue/metabolism , Body Mass Index , Inflammation/metabolism , Insulin Resistance , Obesity, Morbid/metabolism , Omentum , Adipocytes/metabolism , Adipocytes/pathology , Adipose Tissue/pathology , Adult , Chemokines/biosynthesis , Chemokines/genetics , Female , Follow-Up Studies , Gene Expression , Humans , Inflammation/genetics , Inflammation/pathology , Male , Middle Aged , Obesity, Morbid/physiopathology , Polymerase Chain Reaction , RNA/genetics , Retrospective Studies
12.
Surg Obes Relat Dis ; 6(3): 237-41, 2010.
Article in English | MEDLINE | ID: mdl-20005785

ABSTRACT

BACKGROUND: Obesity is associated with a pathologic predominance of sympathetic over parasympathetic tone. With respect to the heart, this autonomic dysfunction presents as a decreased heart rate variability (HRV), which has been associated with increased cardiovascular morbidity. Gastric bypass (GB) reduces cardiovascular mortality, and, thus, could beneficially affect the HRV. We sought to identify the factors predictive of HRV in a severely obese population of undergoing GB at a university hospital in the United States. METHODS: The data of all patients presenting for GB were included in a prospective database. The homeostatic model of assessment (HOMA) was used to calculate the insulin resistance and glucose disposition index. A 24-hour Holter monitor was used to assess the HRV. Measurements were repeated at 2 weeks and 6 months postoperatively. The correlations between variables were determined using linear mixed models. RESULTS: We studied 30 patients undergoing GB. All exhibited some degree of reduced HRV that improved postoperatively. The HOMA-insulin resistance inversely correlated with the HRV, and the HOMA-glucose disposition index directly correlated with the parameters of HRV in our longitudinal models. Weight, body mass index, excess body weight, gender, and age did not correlate with HRV. Improvements in HRV correlated with reductions in the average heart rate, underscoring a postoperative increase in relative vagal tone. CONCLUSION: HRV in the severely obese is better predicted by the degree of insulin resistance, than by the degree of obesity, age, or gender. GB led to an improvement in HRV, the magnitude of which correlated with the change in insulin resistance and glucose disposition index, but not with weight loss.


Subject(s)
Gastric Bypass , Heart Conduction System/physiopathology , Heart Rate/physiology , Insulin Resistance , Obesity, Morbid/physiopathology , Obesity, Morbid/surgery , Adult , Age Factors , Blood Glucose/analysis , Electrocardiography, Ambulatory , Female , Humans , Insulin/blood , Linear Models , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Sex Factors , Treatment Outcome
13.
J Comput Assist Tomogr ; 33(3): 369-75, 2009.
Article in English | MEDLINE | ID: mdl-19478629

ABSTRACT

PURPOSE: The purpose of this study was to review the etiology and computed tomography (CT) findings of small-bowel obstruction (SBO) in patients who have undergone bariatric laparoscopic Roux-en-Y gastric bypass (LGBP) surgery. MATERIALS AND METHODS: Prospectively entered data from a surgical database of 835 consecutive patients who underwent antecolic-antegastric LGBP for morbid obesity from June 1999 to April 2005 in a single institution were retrospectively reviewed. A total of 42 cases of bowel obstruction were observed in 41 patients. Surgical proof was available in 38 cases, and 4 cases had characteristic imaging features and/or clinical follow-up. Seventeen CT scans were reviewed to determine cause and level of obstruction, and this was correlated with surgical findings and clinical follow-up. RESULTS: Internal hernia was the most common (13 cases) and also the most frequently missed etiology of SBO on CT scans, with the diagnosis being made prospectively in only 2 of 6 cases, in which CT was done. Adhesions, ventral hernia, postoperative ileus, and jejunojejunal (JJ) anastomotic strictures, in that order, were the other commonly observed etiologies for SBO, with 11, 7, 5, and 4 cases, respectively. Some causes of SBO post-LGBP (JJ anastomotic stricture and postoperative ileus) developed relatively early, whereas others (internal hernia) tended to develop later or had a bimodal distribution (adhesions and ventral hernia). Fifteen (36%) of 42 cases had SBO at or near the level of jejunojejunostomy site; causes included internal hernia (5 cases), adhesions/kinking of small bowel (5 cases), JJ anastomotic stricture (4 cases), and JJ intussusception (1 case). CONCLUSION: The time interval between LGBP and development of SBO might provide a useful clinical clue to its etiology. The JJ level is an important location for SBO post-LGBP because of a variety of causes, and special attention must be paid to this site at imaging of post-LGBP patients.


Subject(s)
Gastric Bypass/statistics & numerical data , Intestinal Obstruction/diagnostic imaging , Intestinal Obstruction/epidemiology , Laparoscopy/statistics & numerical data , Postoperative Complications/diagnostic imaging , Postoperative Complications/epidemiology , Adult , Comorbidity , Female , Hernia/diagnostic imaging , Hernia/epidemiology , Humans , Incidence , Male , Massachusetts/epidemiology , Middle Aged , Radiography , Retrospective Studies , Risk Assessment/methods , Risk Factors , Young Adult
14.
Surg Obes Relat Dis ; 5(4): 439-43, 2009.
Article in English | MEDLINE | ID: mdl-19342311

ABSTRACT

BACKGROUND: As the number of laparoscopic adjustable gastric bands (LAGBs) placed has increased, the number of patients requiring removal of the device has also increased. METHODS: The data from our institution, a U.S. university medical center, were reviewed to determine the feasibility, patient characteristics, and early results of converting patients from LAGB to laparoscopic Roux-en-Y gastric bypass. RESULTS: A total of 350 patients underwent LAGB placement at our institution from 2001 to 2008. Of these, 26 required conversion to laparoscopic Roux-en-Y gastric bypass for the following reasons: slippage, poor weight loss, LAGB intolerance, esophageal dilation, infection, and gastric ischemia. All conversions were completed laparoscopically. The average operating time and length of stay was 160 minutes and 3 days, respectively. Three complications developed. The average interval to conversion was 29 months. The average follow-up after conversion was 18 months. The average percentage of excess body weight loss at conversion was 23%. At 12 months after conversion, the patients had achieved an average percentage of excess body weight loss of 56% from their pre-LAGB weight. CONCLUSION: The increasing popularity of the LAGB has led to a considerable number of revisions of the device. Our early experience has shown that converting patients from LAGB to laparoscopic Roux-en-Y gastric bypass is feasible and safe and can offer patients substantial additional weight loss.


Subject(s)
Gastric Bypass , Gastroplasty , Laparoscopy , Obesity/surgery , Adult , Aged , Body Mass Index , Cohort Studies , Feasibility Studies , Female , Gastroplasty/adverse effects , Humans , Male , Middle Aged , Obesity/complications , Reoperation , Retrospective Studies , Treatment Failure , Weight Loss
15.
Int J Colorectal Dis ; 24(7): 797-801, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19165490

ABSTRACT

BACKGROUND: The traditional therapy for perforated sigmoid diverticulitis with peritonitis is emergency colectomy usually with colostomy. We report laparoscopic exploration with peritoneal lavage as an alternative in seven patients who required emergency surgery for diverticulitis. METHODS: Six patients presented with diffuse peritonitis and one with a failure of percutaneous therapy. All patients were explored laparoscopically and the peritoneal cavity was lavaged with saline in addition to receiving intravenous antibiotics. Patient demographics, clinical response, length of stay, and complications were recorded. RESULTS: Six patients had resolution of peritonitis resolved and patients were discharged from the hospital. One of these patients who developed a pelvic abscess required a percutaneous drainage postoperatively. This patient ultimately returned 3 months later with recurrent symptoms and underwent colectomy with primary anastomosis. One patient failed to improve initially and underwent colectomy with primary anastomosis on the same admission. Five patients subsequently had elective sigmoid resections, four laparoscopic and one open. Mean length of stay was 7.7 days. There was no mortality. CONCLUSION: We conclude that laparoscopic exploration and peritoneal lavage can be performed safely in patients with diffuse, purulent peritonitis. Using this approach, most patients with purulent peritonitis can avoid emergent laparotomy with the risk of colostomy, and the need for a second surgery.


Subject(s)
Colon, Sigmoid/pathology , Colon, Sigmoid/surgery , Diverticulitis/surgery , Laparoscopy , Peritoneal Lavage , Adult , Aged , Demography , Female , Humans , Male , Middle Aged
16.
Proc Natl Acad Sci U S A ; 105(22): 7833-8, 2008 Jun 03.
Article in English | MEDLINE | ID: mdl-18509062

ABSTRACT

Storage of energy as triglyceride in large adipose-specific lipid droplets is a fundamental need in all mammals. Efficient sequestration of fat in adipocytes also prevents fatty acid overload in skeletal muscle and liver, which can impair insulin signaling. Here we report that the Cide domain-containing protein Cidea, previously thought to be a mitochondrial protein, colocalizes around lipid droplets with perilipin, a regulator of lipolysis. Cidea-GFP greatly enhances lipid droplet size when ectopically expressed in preadipocytes or COS cells. These results explain previous findings showing that depletion of Cidea with RNAi markedly elevates lipolysis in human adipocytes. Like perilipin, Cidea and the related lipid droplet protein Cidec/FSP27 are controlled by peroxisome proliferator-activated receptor gamma (PPARgamma). Treatment of lean or obese mice with the PPARgamma agonist rosiglitazone markedly up-regulates Cidea expression in white adipose tissue (WAT), increasing lipid deposition. Strikingly, in both omental and s.c. WAT from BMI-matched obese humans, expression of Cidea, Cidec/FSP27, and perilipin correlates positively with insulin sensitivity (HOMA-IR index). Thus, Cidea and other lipid droplet proteins define a novel, highly regulated pathway of triglyceride deposition in human WAT. The data support a model whereby failure of this pathway results in ectopic lipid accumulation, insulin resistance, and its associated comorbidities in humans.


Subject(s)
Adipose Tissue, White/metabolism , Apoptosis Regulatory Proteins/metabolism , Insulin Resistance , Triglycerides/metabolism , 3T3-L1 Cells , Adipocytes/metabolism , Adipose Tissue, White/cytology , Amino Acid Sequence , Animals , Apoptosis Regulatory Proteins/analysis , Apoptosis Regulatory Proteins/genetics , Body Mass Index , Carrier Proteins , Humans , Lipolysis , Male , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Obesity/metabolism , PPAR gamma/agonists , PPAR gamma/genetics , PPAR gamma/metabolism , Perilipin-1 , Phosphoproteins/analysis , Phosphoproteins/metabolism , Proteins/genetics , Proteins/metabolism , RNA Interference , RNA, Messenger/metabolism , Rosiglitazone , Thiazolidinediones/pharmacology
17.
Surg Innov ; 15(1): 26-31, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18407927

ABSTRACT

Use of laparoscopy in penetrating trauma has been well established; however, its application in blunt trauma is evolving. The authors hypothesized that laparoscopy is safe and feasible as a diagnostic and therapeutic modality in both the patients with penetrating and blunt trauma. Trauma registry data and medical records of consecutive patients who underwent laparoscopy for abdominal trauma were reviewed. Over a 4-year period, 43 patients (18 blunt trauma / 25 penetrating trauma) underwent a diagnostic laparoscopy. Conversion to laparotomy occurred in 9 (50%) blunt trauma and 9 (36%) penetrating trauma patients. Diagnostic laparoscopy was negative in 33% of blunt trauma and 52% of penetrating trauma patients. Sensitivity/specificity of laparoscopy in patients with blunt and penetrating trauma was 92%/100% and 90%/100%, respectively. Overall, laparotomy was avoided in 25 (58%) patients. Use of laparoscopy in selected patients with blunt and penetrating abdominal trauma is safe, minimizes nontherapeutic laparotomies, and allows for minimal invasive management of selected intra-abdominal injuries.


Subject(s)
Abdominal Injuries/surgery , Laparoscopy , Wounds, Nonpenetrating/surgery , Wounds, Stab/surgery , Abdominal Injuries/diagnosis , Adult , Female , Humans , Laparotomy , Male , Sensitivity and Specificity , Treatment Outcome , Wounds, Nonpenetrating/diagnosis , Wounds, Stab/diagnosis
18.
J Gastrointest Surg ; 11(9): 1083-90, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17588192

ABSTRACT

INTRODUCTION: Obese individuals may have normal insulin-glucose homeostasis, insulin resistance, or diabetes mellitus. Whereas gastric bypass cures insulin resistance and diabetes mellitus, its effects on normal physiology have not been described. We studied insulin resistance and beta-cell function for patients undergoing gastric bypass. METHODS: One hundred thirty-eight patients undergoing gastric bypass had fasting insulin and glucose levels drawn on days 0, 12, 40, 180, and 365. Thirty-one (22%) patients with diabetes mellitus were excluded from this analysis. Homeostatic model of assessment was used to estimate insulin resistance, insulin sensitivity, and beta-cell function. Based on this model, patients were categorized as high insulin resistance if their insulin resistance was >2.3. RESULTS: Body mass index did not correlate with insulin resistance. Forty-seven (34%) patients were categorized as high insulin resistance. Correction of insulin resistance for this group occurred by 12 days postoperatively. Sixty (43%) patients were categorized as low insulin resistance. They demonstrated an increase of beta-cell function by 12 days postoperatively, which returned to baseline by 6 months. At 1 year postoperatively, the low insulin resistance group had significantly higher beta-cell function per degree of insulin sensitivity. CONCLUSIONS: Adipose mass alone cannot explain insulin resistance. Severely obese individuals can be categorized by degree of insulin resistance, and the effect of gastric bypass depends upon this preoperative physiology.


Subject(s)
Glucose/metabolism , Homeostasis/physiology , Insulin Resistance/physiology , Insulin/metabolism , Obesity, Morbid/metabolism , Adipose Tissue/metabolism , Adult , B-Lymphocytes/physiology , Body Mass Index , Female , Gastric Bypass , Humans , Immunoassay , Luminescent Measurements , Male , Middle Aged , Obesity, Morbid/physiopathology , Obesity, Morbid/surgery
19.
J Lipid Res ; 48(2): 465-71, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17093294

ABSTRACT

Cultured adipocyte cell lines are a model system widely used to study adipose function, but they exhibit significant physiological differences compared with primary cells from adipose tissue. Here we report short interfering RNA-based methodology to selectively attenuate gene expression in mouse and human primary adipose tissues as a means of rapidly validating findings made in cultured adipocyte cell lines. The method is exemplified by depletion of the PTEN phosphatase in white adipose tissue (WAT) from mouse and humans, which increases Akt phosphorylation as expected. This technology is also shown to silence genes in mouse brown adipose tissue. Previous work revealed upregulation of the mitochondrial protein UCP1 in adipose cells from mice lacking the gene for the transcriptional corepressor RIP140, whereas in cultured adipocytes, loss of RIP140 has a little effect on UCP1 expression. Application of our method to deplete RIP140 in primary mouse WAT elicited markedly increased oxygen consumption and expression of UCP1 that exactly mimics the phenotype observed in RIP140-null mice. This ex-vivo method of gene silencing should be useful in rapid validation studies as well as in addressing the depot- and species-specific functions of genes in adipose biology.


Subject(s)
Adipose Tissue, White/metabolism , RNA Interference , Adaptor Proteins, Signal Transducing/metabolism , Animals , Cells, Cultured , Gene Expression Regulation , Glucose/metabolism , Glucose Transporter Type 1/genetics , Glucose Transporter Type 4/genetics , Humans , Male , Mice , Nuclear Proteins/metabolism , Nuclear Receptor Interacting Protein 1 , PTEN Phosphohydrolase/metabolism , Phosphorylation , Proto-Oncogene Proteins c-akt/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Up-Regulation
20.
Obes Surg ; 16(9): 1227-31, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16989709

ABSTRACT

BACKGROUND: Weight loss after bariatric surgery varies and depends on many factors, such as time elapsed since surgery, baseline weight, and co-morbidities. METHODS: We analyzed weight data from 494 patients who underwent laparoscopic Roux-en-Y gastric bypass (RYGBP) by one surgeon at an academic institution between June 1999 and December 2004. Linear regression was used to identify factors in predicting % excess weight loss (%EWL) at 1 year. RESULTS: Mean patient age at time of surgery was 44 +/- 9.6 (SD), and the majority were female (83.8%). The baseline prevalence of co-morbidities included 24% for diabetes, 42% for hypertension, and 15% for hypercholesterolemia. Baseline BMI was 51.5 +/- 8.5 kg/m(2). Mean length of hospital stay was 3.8 +/- 4.6 days. Mortality rate was 0.6%. Follow-up weight data were available for 90% of patients at 6 months after RYGBP, 90% at 1 year, and 51% at 2 years. Mean %EWL at 1 year was 65 +/- 15.2%. The success rate (> or = 50 %EWL) at 1 year was 85%. Younger age and lower baseline weight predicted greater weight loss. Males lost more weight than females. Diabetes was associated with a lower %EWL. Depression did not significantly predict %EWL. CONCLUSION: The study demonstrated a 65 %EWL and 85% success rate at 1 year in our bariatric surgery program. Our finding that most pre-surgery co-morbidities and depression did not predict weight loss may have implications for pre-surgery screening.


Subject(s)
Gastric Bypass , Laparoscopy , Obesity, Morbid/surgery , Weight Loss , Adult , Age Factors , Aged , Female , Follow-Up Studies , Humans , Length of Stay , Male , Middle Aged , Obesity, Morbid/complications , Predictive Value of Tests , Sex Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...